AI assistant
InspireMD, Inc. — Director's Dealing 2016
Mar 23, 2016
34187_dirs_2016-03-23_b9e4e3ea-20e5-4e9e-8fd9-8cdc3d2d9321.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2016-03-21
Reporting Person: Stuka Paul (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-21 | Common Stock | P | 127119 | $0.59 | Acquired | 267060 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-21 | Warrants to Purchase Common Stock | $0.59 | P | 63560 | Acquired | 2021-03-21 | Common Stock (63560) | Indirect |
Footnotes
F1: The Common Stock and Warrants to purchase Common Stock were acquired as components of Units, each Unit consisting of one share of Common Stock and a Warrant to purchase one half of one share of Common Stock, at a purchase price per Unit of $0.59.
F2: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.